logo







Home>Companies>Beam-therapeutics-nas-beam


Beam therapeutics (nas: beam)

Beam therapeutics (nas: beam)



Beam Therapeutics (NAS: BEAM) is a biotechnology company focused on developing innovative genetic medicines utilizing its proprietary base editing technology to precisely target individual bases in the genome.
Sign up today to get real-time market insights on Beam therapeutics (nas: beam) and hundreds of other pre-IPO companies



Beam therapeutics (nas: beam) Overview

Cambridge, MA, United States
2017
Biotech
https://www.beamtx.com



Beam therapeutics (nas: beam) Live Market Data

$00000000
$00000000




Beam therapeutics (nas: beam) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO2/5/2020
Series B3/6/2019
Series A5/14/2018




Beam therapeutics (nas: beam) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
ARCH Venture PartnersSeries B, Series ASeries B (2019-03-06)
DHVCSeries ASeries A (2018-05-14)
Dreamers VCSeries ASeries A (2018-05-14)
Eight RoadsSeries B, Series ASeries B (2019-03-06)
F-Prime CapitalSeries B, Series ASeries B (2019-03-06)
Altitude Life Science VenturesSeries BSeries B (2019-03-06)
GV
Series B
Series B (2019-03-06)




Beam therapeutics (nas: beam) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Beam therapeutics (nas: beam) data




Beam therapeutics (nas: beam) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Beam therapeutics (nas: beam) data




Latest Beam therapeutics (nas: beam) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.